NCT06956014ClinicalTrials.gov
Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy
Multicenter, Double-blind, Randomized, Placebo-controlled Phase III Trial to Evaluate the Efficacy and Safety of the Full-spectrum Cannabis Extract VER-01 in Participants With Chronic Painful Lumbosacral Radiculopathy
باختصار
The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not…
المرحلة 3مطلوب 810 مشاركين43 موقعاًدولة واحدة
الفئات
مسجَّلة في سجل واحد
- ClinicalTrials.govNCT06956014فتح هذا السجل في ClinicalTrials.govتمت المزامنة أول أمس
يمكن أن تُسجَّل دراسة واحدة في عدة سجلات. نعرضها مرة واحدة ونربط بكل سجل نحتفظ به.
تُعرض معلومات التجربة كما نشرها السجل، بلغتها الأصلية.
هل أنت مهتم بهذه الدراسة؟
تسجيل الدخول أو أنشئ حسابًا لتسجيل اهتمامك ومتابعة هذه الدراسة.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Present: Registered before enrolment beganFirst posted 2025-05-02; recorded start 2026-09-22
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Present: Participants are randomly assignedAllocation is recorded as randomised
- Present: Has a comparison groupThe record lists a placebo or comparator arm, or more than one study arm
- Present: Uses blinding (masking)A masking level is recorded in the record
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 2 other studies in this databaseCounted from the lead sponsor named in the record (Vertanical GmbH)
- Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database
- The record lists 1 condition.
- Lead sponsor type recorded as: industry.
- Intervention regulatory context: investigational, within a phased regulatory pathway.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
A strong methodological design for a phase 3 study, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation20/20
Participants are randomly allocated between arms
- Blinding20/20
Quadruple-blind
- Control arm13/15
Placebo / sham control arm
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre0/8
Single site, or site count not stated
- Data monitoring committee0/7
No data monitoring committee stated
- Prospective registration5/5
Registered before the study start date
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A medium-sized study: 810 participants (target), run at 43 sites.
How this score is built
- Enrolment29/40
810 participants (target)
- Site count0/25
Site count not stated in the record
- Country count0/15
Country count not stated in the record
- Planned duration7/10
Planned over about 24 months
- Sponsor scale1/10
Vertanical GmbH has led 3 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
ملخص
The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not led to sufficient pain relief or were unsuitable due to contraindications or intolerance.
الحالات
- Lumbosacral Radiculopathy
الأهلية
| الجنس | الجميع |
|---|---|
| الأعمار | 18 Years – لا حد أقصى |
| المتطوعون الأصحّاء | لا |
الأهلية كما كُتبت في السجل
الأهلية في عبارات بسيطة
لم تُقسَّم معايير هذا السجل إلى عبارات منفصلة بعد. نص السجل أعلاه كامل وهو النسخة المُعتمَدة.
تصميم الدراسة
| نوع الدراسة | تدخّلية |
|---|---|
| المرحلة | المرحلة 3 |
| التخصيص | معشّاة |
| نموذج التدخّل | PARALLEL |
| الغرض الأساسي | TREATMENT |
| التعمية | QUADRUPLE (4) |
| التجنيد | مطلوب 810 مشاركين |
الجهة الراعية والمتعاونون
- Vertanical GmbH الجهة الراعية
الأذرع والتدخلات
- VER-01 Dose 1EXPERIMENTAL
- VER-01 Dose 2EXPERIMENTAL
- PlaceboPLACEBO_COMPARATOR
التدخلات
- أخرى Placebo
Comparator without active ingredient
- دواء VER-01
Standardized soft extract from Cannabis sativa DKJ127 L., cannabis flos (Cannabis flower), corresponding to 19 mg Δ9-Tetrahydrocannabinol (THC) per ml drug product
مقاييس النتائج
مقياس النتيجة الأولي
Efficacy based on pain reduction
The primary endpoint is the absolute change in mean leg pain intensity in the index leg measured on an 11-point numerical rating scale (NRS) at Treatment Week 12 compared to Baseline.
الإطار الزمني From Baseline to Treatment Week 12
التواريخ
| تاريخ البدء | 22 سبتمبر 2026 (فعلي) |
|---|---|
| الإتمام الأولي | 1 سبتمبر 2028 (تقديري) |
| الإتمام | 1 سبتمبر 2028 (تقديري) |
| أول نشر | 2 مايو 2025 (فعلي) |
| آخر تحديث | 19 نوفمبر 2026 |
| النتائج منشورة | غير مذكور في سجل السجل |
| آخر تأكيد للحالة | نوفمبر 2026 |
فعلي يعني أن الحدث وقع. تقديري يعني أن الجهة الراعية تتوقعه. للكلمتين معنيان مختلفان.
المواقع
43 موقعاً قيد التجنيد
United States
| المنشأة | المدينة | الولاية أو المنطقة | الحالة |
|---|---|---|---|
| Central Texas Clinical Research, LLC | Austin | Texas | قيد التجنيد |
| Boston Clinical Trials | Boston | Massachusetts | قيد التجنيد |
| Bradenton Research Center | Bradenton | Florida | قيد التجنيد |
| DFW Clinical Trials | Carrollton | Texas | قيد التجنيد |
| Epic Medical Research - Carrolton | Carrollton | Texas | قيد التجنيد |
| Clinitiative - Clinical Trials of South Carolina - Charleston | Charleston | South Carolina | قيد التجنيد |
| Epic Medical Research - Chickasha | Chickasha | Oklahoma | قيد التجنيد |
| Velocity Clinical Research - Cleveland | Cleveland | Ohio | قيد التجنيد |
| Epic Medical Research - DeSoto | DeSoto | Texas | قيد التجنيد |
| Mountain View Clinical Research | Denver | Colorado | قيد التجنيد |
| Innovare Research Group I | Friendswood | Texas | قيد التجنيد |
| AGA Clinical Trials | Hialeah | Florida | قيد التجنيد |
| HD Research - Memorial Hermann Village | Houston | Texas | قيد التجنيد |
| Perfizien Clinical Research LLC | Houston | Texas | قيد التجنيد |
| Synergy Groups Medical - Southeast Houston | Houston | Texas | قيد التجنيد |
| Green Leaf Clinical Trials | Jacksonville | Florida | قيد التجنيد |
| R & H Clinical Research | Katy | Texas | قيد التجنيد |
| Alliance for Multispecialty Research - Knoxville | Knoxville | Tennessee | قيد التجنيد |
| Epic Clinical Research - Lewisville | Lewisville | Texas | قيد التجنيد |
| Central Medical Research Institute | Long Beach | California | قيد التجنيد |
| Tekton Research - Longmont | Longmont | Colorado | قيد التجنيد |
| K2 Medical Research - Maitland II | Maitland | Florida | قيد التجنيد |
| Velocity Clinical Research - Medford | Medford | Oregon | قيد التجنيد |
| Alma Clinical Research | Miami | Florida | قيد التجنيد |
| Floridian Research Institute LLC I | Miami | Florida | قيد التجنيد |
| AMR Mobile | Mobile | Alabama | قيد التجنيد |
| Monroe Biomedical Research - Monroe | Monroe | North Carolina | قيد التجنيد |
| Alliance for Multispecialty Research - Norfolk | Norfolk | Virginia | قيد التجنيد |
| Conquest Research - Lake Nona | Orlando | Florida | قيد التجنيد |
| Alfa Medical Research - Pembroke Pines | Pembroke Pines | Florida | قيد التجنيد |
| Flourish Research - Philadelphia | Plymouth Meeting | Pennsylvania | قيد التجنيد |
| United Medical Research | Port Orange | Florida | قيد التجنيد |
| Boeson Research | Provo | Utah | قيد التجنيد |
| CenExel JBR - Salt Lake City | Salt Lake City | Utah | قيد التجنيد |
| Elixia Clinical Research Collaborative | Springfield | Massachusetts | قيد التجنيد |
| Professional Health Care of Pinellas | St. Petersburg | Florida | قيد التجنيد |
| Velocity Clinical Research - Suffolk | Suffolk | Virginia | قيد التجنيد |
| Alliance for Multispecialty Research - Tempe I | Tempe | Arizona | قيد التجنيد |
| Alliance for Multispecialty Research - Wichita East | Wichita | Kansas | قيد التجنيد |
| Grayline Research Center | Wichita Falls | Texas | قيد التجنيد |
| Progressive Medicine of the Triad, LLC | Winston-Salem | North Carolina | قيد التجنيد |
| Conquest Research - Winter Park | Winter Park | Florida | قيد التجنيد |
| Vitalix Clinical | Worcester | Massachusetts | قيد التجنيد |
مستندات الدراسة
لا تُرتبط أي مستندات في سجل السجل هذا.
التغيّرات عبر الزمن
- 19 نوفمبر 2026
أُضيف موقع
11 sites added (43 total)
3243
- 2 نوفمبر 2026
أُضيف موقع
9 sites added (32 total)
2332
- 21 أكتوبر 2026
أُضيف موقع
1 site added (23 total)
2223
- 19 أكتوبر 2026
أُضيف موقع
21 sites added (22 total)
122
- 28 سبتمبر 2026
تغيّرت الحالة
Status changed from Not yet recruiting to Recruiting
NOT_YET_RECRUITINGRECRUITING
- 28 سبتمبر 2026
أُضيف موقع
1 site added (1 total)
01
- 28 سبتمبر 2026
فُتح التجنيد
Recruitment opened
NOT_YET_RECRUITINGRECRUITING